NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Relief Cardiovascular

Relief Cardiovascular

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://www.reliefcardio.com/

Last Round

Series A

Jan 8, 2025

Total Funding Raised

$12M

Company Overview

Relief Cardiovascular is a medical device company that is developing the Relief System, a transcatheter smart implant designed to monitor and modulate venous pressure to manage congestion in heart failure patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

transcatheter smart implantheart failure devicehemodynamic monitoringfluid managementMedTechcardiovascular deviceblood flow modulationimplantable sensordiuretic resistanceinterventional cardiologyAI-augmented deviceHealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Relief Cardiovascular Comparables

Compare Relief Cardiovascular with similar companies based on industry and business-model similarity.

Relief Cardiovascular comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Relief Cardiovascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 8, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Brent Ratz

CEO, Managing Director, And Founder

Founding Team

Relief Cardiovascular Investors

Notable investors and investment history

Relief Cardiovascular investors
InvestorRounds
Good Growth CapitalSeries A
Advent Life SciencesSeries A
Broadview VenturesSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2025

    $12M round led by Advent Life Sciences and Broadview Ventures.

View all signals

Relief Cardiovascular Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Relief Cardiovascular Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Relief Cardiovascular's valuation, stock price, and market status.

Firmographic Details

HeadquartersIrvine, California
Employee Range17
Year Founded2022
Last FundingJan 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.